SCHEMBL7384167

SCHEMBL7384167

COc1ccc(CC/N=c2/scc(C3(c4ccc(Cl)cc4)CCC3)n2CCc2ccc(OC)c(OC)c2)cc1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
KDM4E B2RXH2 1/20 0.43
SMN1; SMN2 Q16637 4/20 0.40
RECQL P46063 1/20 0.40
KMT2A Q03164 1/20 0.40
POLB P06746 1/20 0.39
HSD11B1 P28845 2/20 0.37
LMNA P02545 4/20 0.36
TP53 P04637 1/20 0.36
MAPT P10636 3/20 0.36
HTT P42858 2/20 0.36
PAX8 Q06710 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
DRD2 P14416 1/20 0.34
DRD3 P35462 1/20 0.34
GAA P10253 1/20 0.34
NR1I2 O75469 1/20 0.34
MAOA P21397 1/20 0.34
PTGS2 P35354 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7384171 1.00 ALDH1A1 (0.43) ALDH1A1KDM4ESMN1; SMN2RECQLKMT2A
Bromide SCHEMBL7382113 0.99 ALDH1A1 (0.42) ALDH1A1KDM4ESMN1; SMN2RECQLKMT2A
Bromide SCHEMBL7382109 0.99 ALDH1A1 (0.42) ALDH1A1KDM4ESMN1; SMN2RECQLKMT2A
SCHEMBL7387019 0.98 ALDH1A1 (0.43) ALDH1A1KDM4ESMN1; SMN2RECQLKMT2A
SCHEMBL7387022 0.98 ALDH1A1 (0.43) ALDH1A1KDM4ESMN1; SMN2RECQLKMT2A
Bromide SCHEMBL7384657 0.97 ALDH1A1 (0.42) ALDH1A1KDM4ESMN1; SMN2RECQLKMT2A
Bromide SCHEMBL7384661 0.97 ALDH1A1 (0.42) ALDH1A1KDM4ESMN1; SMN2RECQLKMT2A
SCHEMBL7384674 0.91 ALDH1A1 (0.41) ALDH1A1KDM4ESMN1; SMN2RECQLKMT2A
SCHEMBL7384676 0.91 ALDH1A1 (0.41) ALDH1A1KDM4ESMN1; SMN2RECQLKMT2A
SCHEMBL7385533 0.91 ALDH1A1 (0.43) ALDH1A1KDM4ESMN1; SMN2KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0970090-B1 SUBSTITUTED 4-ARYLMETHYLENE-2-IMINO-2,3-DIHYDROTHIAZOLES AND DERIVATIVES AND THEIR PHARMACEUTICAL USE KNOLL GMBH (DE) 2002-06-05 EP claimed
US-6187802-B1 3-(1-(3,4-DICHLOROPHENYL)CYCLOBUTYL)-5,6-DIHYDROIMIDAZO(2,1-B) THIAZOLE, FOR EXAMPLE; ADMINISTERING TO TREAT DEPRESSION, ANXIETY, PARKINSON'S DISEASE, OBESITY, COGNITIVE DISORDERS, SEIZURES, AND FOR NEUROPROTECTION AGAINST STROKE KNOLL AKTIENGESELLSCHAFT (DE) 2001-02-13 US claimed
EP-0970090-A1 SUBSTITUTED 4-ARYLMETHYLENE-2-IMINO-2,3-DIHYDROTHIAZOLES AND DERIVATIVES AND THEIR PHARMACEUTICAL USE Knoll AG (DE) 2000-01-12 EP claimed
WO-1998041528-A1 SUBSTITUTED 4-ARYLMETHYLENE-2-IMINO-2,3-DIHYDROTHIAZOLES AND DERIVATIVES AND THEIR PHARMACEUTICAL USE KNOLL AKTIENGESELLSCHAFT (DE) 1998-09-24 WO claimed
EP-0970090-B1 SUBSTITUTED 4-ARYLMETHYLENE-2-IMINO-2,3-DIHYDROTHIAZOLES AND DERIVATIVES AND THEIR PHARMACEUTICAL USE KNOLL GMBH (DE) 2002-06-05 EP disclosed
US-6187802-B1 3-(1-(3,4-DICHLOROPHENYL)CYCLOBUTYL)-5,6-DIHYDROIMIDAZO(2,1-B) THIAZOLE, FOR EXAMPLE; ADMINISTERING TO TREAT DEPRESSION, ANXIETY, PARKINSON'S DISEASE, OBESITY, COGNITIVE DISORDERS, SEIZURES, AND FOR NEUROPROTECTION AGAINST STROKE KNOLL AKTIENGESELLSCHAFT (DE) 2001-02-13 US disclosed
EP-0970090-A1 SUBSTITUTED 4-ARYLMETHYLENE-2-IMINO-2,3-DIHYDROTHIAZOLES AND DERIVATIVES AND THEIR PHARMACEUTICAL USE Knoll AG (DE) 2000-01-12 EP disclosed
WO-1998041528-A1 SUBSTITUTED 4-ARYLMETHYLENE-2-IMINO-2,3-DIHYDROTHIAZOLES AND DERIVATIVES AND THEIR PHARMACEUTICAL USE KNOLL AKTIENGESELLSCHAFT (DE) 1998-09-24 WO disclosed